Lyell Immunopharma
NASDAQ: LYEL
NYSE

Healthcare
Biotechnology
Global Rank
#20911
Country Rank
n/a
Market Cap
169.7 M
Price
11.46
Change (%)
14.92%
Volume
785,781
Lyell Immunopharma (NASDAQ: LYEL) Stock Split History
This company has undergone a total of one stock splits throughout its history. One reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on 06/02/2025 with a ratio of 1-for-20. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
Date | Split Ratio | Multiple | Cumulative multiple | Type |
---|---|---|---|---|
06/02/2025 | 1:20 | x0.05 | x0.05 | Reverse |
Frequently Asked Questions
-
How much would Lyell Immunopharma stock be worth if it never split?If Lyell Immunopharma (stock symbol: NASDAQ: LYEL) had never undergone any stock splits, its price per share today would be approximately 0.57 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-20) that occurred on 06/02/2025.
-
Has Lyell Immunopharma stock ever split?Lyell Immunopharma (stock symbol: NASDAQ: LYEL) has undergone a total of one stock splits. The most recent split occurred on 06/02/2025. One share bought prior to the first split on 06/02/2025 would now equal 0.05 shares.
-
Will Lyell Immunopharma stock split again?Lyell Immunopharma (stock symbol: NASDAQ: LYEL) has undergone one stock splits in its history. The most recent split, a 1-for-20 split, occurred on 06/02/2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.